Vor Biopharma holder reports 2,836,539-share stake
Vor Biopharma Inc. received an initial insider ownership report from TCG Crossover investment entities.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Vor Biopharma Inc. received an initial insider ownership report from TCG Crossover investment entities. The filing shows indirect holdings of 2,836,539 shares of Vor Biopharma common stock as of March 30, 2026, with TCG Crossover funds and their general partners reported as ten percent owners sharing voting, investment, and dispositive power.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
TCG Crossover GP II, LLC, TCG Crossover Fund II, L.P., TCG Crossover GP III, LLC, TCG Crossover Fund III, L.P.
Role
10% Owner | 10% Owner | 10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Common Stock — 5,673,078 shares (Indirect, See footnote)
Footnotes (2)
- F1. These securities are held of record by TCG Crossover Fund II, L.P. (TCG Crossover II). TCG Crossover GP II, LLC (TCG Crossover GP II) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities.
- F2. These securities are held of record by TCG Crossover Fund III, L.P. (TCG Crossover III). TCG Crossover GP III, LLC (TCG Crossover GP III) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities.
Key Figures
Indirect common shares held: 2,836,539 shares
Holding entries: 2
Unknown transaction records: 2
+1 more
4 metrics
Indirect common shares held
2,836,539 shares
Total shares following holding entries as of March 30, 2026
Holding entries
2
Number of holding-type records in the Form 3 summary
Unknown transaction records
2
Transactions with unknown direction in transactionSummary
Buy and sell transactions
0 buys, 0 sells
No recorded purchases or sales in this filing
Key Terms
ten percent owner, indirect, dispositive power, beneficial ownership
4 terms
ten percent owner regulatory
"each reporting person is identified as a ten percent owner"
indirect financial
"total_shares_following_transaction shows indirect ownership (ownership_type "indirect")"
dispositive power financial
"may be deemed to have voting, investment, and dispositive power with respect to these securities"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
beneficial ownership regulatory
"initial statement of beneficial ownership of securities by TCG Crossover entities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Vor Biopharma (VOR) Form 3 filing show about insider ownership?
The Form 3 shows that TCG Crossover investment entities are ten percent owners of Vor Biopharma, reporting indirect holdings of 2,836,539 common shares as of March 30, 2026. These holdings are reported through limited partnerships and their general partners.
Who are the reporting persons in Vor Biopharma (VOR)'s Form 3 filing?
The reporting persons are TCG Crossover GP II, LLC, TCG Crossover Fund II, L.P., TCG Crossover GP III, LLC, and TCG Crossover Fund III, L.P.. Each is identified as a ten percent owner of Vor Biopharma Inc.
Does the Vor Biopharma (VOR) Form 3 indicate any recent insider buying or selling?
No buying or selling is indicated. The Form 3 shows holding entries only, with transaction direction marked as unknown and zero recorded buy, sell, or exercise transactions. It functions as an initial statement of beneficial ownership rather than a trade report.
AI-generated analysis. How Rhea-AI works. Not financial advice.
